Jean-Philippe Oster

753 total citations
14 papers, 112 citations indexed

About

Jean-Philippe Oster is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jean-Philippe Oster has authored 14 papers receiving a total of 112 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Jean-Philippe Oster's work include Asthma and respiratory diseases (7 papers), Allergic Rhinitis and Sensitization (3 papers) and Food Allergy and Anaphylaxis Research (2 papers). Jean-Philippe Oster is often cited by papers focused on Asthma and respiratory diseases (7 papers), Allergic Rhinitis and Sensitization (3 papers) and Food Allergy and Anaphylaxis Research (2 papers). Jean-Philippe Oster collaborates with scholars based in France, French Polynesia and Spain. Jean-Philippe Oster's co-authors include Gabrielle Pauli, D. Debieuvre, Gabriel Peltre, Hélène Sénéchal, Marc Busson, Y Aron, A. Prudhomme, Antoine Lévy, M Grivaux and Chantal Rahérison and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Jean-Philippe Oster

12 papers receiving 110 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean-Philippe Oster France 5 51 40 40 32 14 14 112
J.T.J.N. Hiltermann Netherlands 3 127 2.5× 87 2.2× 52 1.3× 18 0.6× 30 2.1× 9 156
F.K. Chung United Kingdom 2 75 1.5× 26 0.7× 37 0.9× 28 0.9× 50 3.6× 2 108
Jamie Redes United States 6 45 0.9× 25 0.6× 41 1.0× 5 0.2× 36 2.6× 8 109
Keisuke Orimo Japan 7 41 0.8× 15 0.4× 23 0.6× 6 0.2× 52 3.7× 11 123
Amanda Rudman Spergel United States 3 91 1.8× 8 0.2× 162 4.0× 10 0.3× 40 2.9× 4 200
Brian Rector United States 4 207 4.1× 152 3.8× 35 0.9× 8 0.3× 69 4.9× 6 255
Dinesh Bagmane United Kingdom 3 38 0.7× 52 1.3× 3 0.1× 10 0.3× 24 1.7× 3 97
Diane Lefaudeux United States 6 84 1.6× 46 1.1× 9 0.2× 17 0.5× 83 5.9× 10 190
Yasuhiko Suga Japan 6 9 0.2× 32 0.8× 4 0.1× 34 1.1× 21 1.5× 13 86
Marija Mitić-Milikić Serbia 9 32 0.6× 88 2.2× 3 0.1× 23 0.7× 14 1.0× 18 149

Countries citing papers authored by Jean-Philippe Oster

Since Specialization
Citations

This map shows the geographic impact of Jean-Philippe Oster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Philippe Oster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Philippe Oster more than expected).

Fields of papers citing papers by Jean-Philippe Oster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-Philippe Oster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Philippe Oster. The network helps show where Jean-Philippe Oster may publish in the future.

Co-authorship network of co-authors of Jean-Philippe Oster

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Philippe Oster. A scholar is included among the top collaborators of Jean-Philippe Oster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Philippe Oster. Jean-Philippe Oster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Tiotiu, Angélica, Francisco Javier González‐Barcala, Pauline Roux, et al.. (2025). Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps. Respiratory Medicine. 238. 107979–107979.
2.
Parrat, Éric, G. Mangiapan, A. Prudhomme, et al.. (2022). Phenotyping to Target Obstructive Sleep Apnoea Syndrom (OSAS) in adults patients with severe asthma. Respiratory Medicine and Research. 82. 100888–100888. 4 indexed citations
3.
Rahérison, Chantal, Laurent Guilleminault, Cécile Chenivesse, et al.. (2022). Updated guidelines (2021) for management and follow-up of asthmatic patients of the French Society of Pneumology (SPLF) and the French Society of Pediatric Pneumology and Allergology (SP2A). Short version. Respiratory Medicine and Research. 81. 100898–100898. 4 indexed citations
4.
Rahérison, Chantal, Éric Parrat, G. Mangiapan, et al.. (2021). FASE-CPHG Study: identification of asthma phenotypes in the French Severe Asthma Study using cluster analysis. Respiratory Research. 22(1). 136–136. 4 indexed citations
5.
Parrat, Éric, G. Mangiapan, A. Prudhomme, et al.. (2019). FASE-CPHG study: a panoramic snapshot of difficult-to-treat, severe asthma in French nonacademic hospitals. ERJ Open Research. 5(4). 69–2019. 9 indexed citations
6.
Parrat, Éric, et al.. (2019). FASE-CPHG Study: A Panoramic Snapshot of Severe Asthma in French Non-Academic Hospitals. SSRN Electronic Journal. 1 indexed citations
7.
Rahérison, Chantal, A. Prudhomme, Jean-Philippe Oster, et al.. (2018). FASE-CPHG Study: Identification of asthma phenotypes in the French Severe Asthma Study using cluster analysis. PA5497–PA5497. 1 indexed citations
8.
Fiteni, Frédéric, Amélie Anota, Franck Bonnetain, et al.. (2016). Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy. European Respiratory Journal. 48(3). 861–872. 14 indexed citations
9.
Debieuvre, D., Jean-Philippe Oster, R Riou, et al.. (2015). The new face of non-small-cell lung cancer in men: Results of two French prospective epidemiological studies conducted 10 years apart. Lung Cancer. 91. 1–6. 21 indexed citations
10.
Pujol, Jean-Louis, A. Lavolé, B. Mennecier, et al.. (2014). Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: Results from the IFCT-0802 trial.. Journal of Clinical Oncology. 32(15_suppl). 7505–7505. 3 indexed citations
11.
Quoix, Élisabeth, Lecia V. Sequist, John Nemunaitis, et al.. (2014). TG4010 immunotherapy combined with first-line therapy in advanced non-small cell lung cancer (NSCLC): phase IIb results of the TIME study. Journal for ImmunoTherapy of Cancer. 2(Suppl 3). O12–O12. 4 indexed citations
13.
Hrabina, M., Ashok Purohit, Jean-Philippe Oster, et al.. (2006). Standardization of an Ash <i>(Fraxinus excelsior) </i>Pollen Allergen Extract. International Archives of Allergy and Immunology. 142(1). 11–18. 16 indexed citations
14.
Sénéchal, Hélène, Marc Busson, Y Aron, et al.. (1999). Genetics and specific immune response in allergy to birch pollen and food: Evidence of a strong, positive association between atopy and the HLA class II allele HLA-DR7☆☆☆★. Journal of Allergy and Clinical Immunology. 104(2). 395–401. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026